CARBOPLATIN DOSING FOR ADULT JAPANESE PATIENTS

Por ANDO, YUICHI, SHIMOKATA, TOMOYA, YASUDA, YOSHINARI, HASEGAWA, YOSHINORI
Publicado no Nagoya J Med Sci (2014)

Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunction

Por Shibata, Takashi, Ebata, Tomoki, Fujita, Ken‐ichi, Shimokata, Tomoya, Maeda, Osamu, Mitsuma, Ayako, Sasaki, Yasutsuna, Nagino, Masato, Ando, Yuichi
Publicado no Cancer Sci (2016)

Correlation Between the Metabolic Conversion of a Capecitabine Metabolite, 5’-Deoxy-5-fluorocytidine, and Creatinine Clearance

Por INAISHI, TAKAHIRO, FUJITA, KEN-ICHI, MATSUMOTO, NATSUMI, SHIMOKATA, TOMOYA, MAEDA, OSAMU, KIKUMORI, TOYONE, HATTORI, NORIFUMI, NAKAYAMA, GORO, ANDO, YUICHI
Publicado no In Vivo (2020)

Muscle wasting associated with the long-term use of mTOR inhibitors

Por Gyawali, Bishal, Shimokata, Tomoya, Honda, Kazunori, Kondoh, Chihiro, Hayashi, Naomi, Yoshino, Yasushi, Sassa, Naoto, Nakano, Yasuyuki, Gotoh, Momokazu, Ando, Yuichi
Publicado no Mol Clin Oncol (2016)

EXTRAVASATION OF PEGYLATED-LIPOSOMAL DOXORUBICIN: FAVORABLE OUTCOME AFTER IMMEDIATE SUBCUTANEOUS ADMINISTRATION OF CORTICOSTEROIDS

Por MITSUMA, AYAKO, SAWAKI, MASATAKA, SHIBATA, TAKASHI, MORITA, SACHI, INADA, MEGUMI, SHIMOKATA, TOMOYA, SUGISHITA, MIHOKO, KITAGAWA, KOICHI, SAWADA, MASAKI, NAWA, AKIHIRO, ANDO, YUICHI
Publicado no Nagoya J Med Sci (2012)

Pazopanib monotherapy in a patient with a malignant granular cell tumor originating from the right orbit: A case report

Por MORITA, SACHI, HIRAMATSU, MARIKO, SUGISHITA, MIHOKO, GYAWALI, BISHAL, SHIBATA, TAKASHI, SHIMOKATA, TOMOYA, URAKAWA, HIROSHI, MITSUMA, AYAKO, MORITANI, SUZUKO, KUBOTA, TOSHINOBU, ICHIHARA, SHU, ANDO, YUICHI
Publicado no Oncol Lett (2015)

Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review

Por Maeda, Osamu, Ohka, Fumiharu, Maesawa, Satoshi, Matsuoka, Ayumu, Shimokata, Tomoya, Mitsuma, Ayako, Urakawa, Hiroshi, Nakamura, Shota, Shimoyama, Yoshie, Nakaguro, Masato, Wakabayashi, Toshihiko, Ando, Yuichi
Publicado no Nagoya J Med Sci (2020)

Phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft‐tissue sarcoma

Por Yonemori, Kan, Kodaira, Makoto, Satoh, Taroh, Kudo, Toshihiro, Takahashi, Shunji, Nakano, Kenji, Ando, Yuichi, Shimokata, Tomoya, Mori, Joji, Inoue, Koichi, Oakley, Gerard J., Sakaguchi, Sachi, Tamura, Kenji
Publicado no Cancer Sci (2018)

Phase I study of the antiprogrammed cell death‐1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignancies

Por Minami, Hironobu, Doi, Toshihiko, Toyoda, Masanori, Imamura, Yoshinori, Kiyota, Naomi, Mitsuma, Ayako, Shimokata, Tomoya, Naito, Yoichi, Matsubara, Nobuaki, Tajima, Takeshi, Tokushige, Kota, Ishihara, Kae, Cameron, Scott, Ando, Yuichi
Publicado no Cancer Sci (2020)

Chemotherapy for biliary tract cancer: real-world experience in a single institute

Por Maeda, Osamu, Ebata, Tomoki, Shimokata, Tomoya, Matsuoka, Ayumu, Inada-Inoue, Megumi, Morita, Sachi, Takano, Yuko, Urakawa, Hiroshi, Miyai, Yuki, Sugishita, Mihoko, Mitsuma, Ayako, Ando, Masahiko, Mizuno, Takashi, Nagino, Masato, Ando, Yuichi
Publicado no Nagoya J Med Sci (2020)